Control group:RCHOP

2 trials

Sponsors

Union Medical College Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology, The First Affiliated Hospital of Zhejiang University Medical College

Conditions

Diffuse large B-cell LymphomaDiffuse large B-cell lymphoma

Early Phase 1

A multicenter, prospective, simultaneous controlled and exploratory clinical study on the treatment of new dignosed Diff typinguse large B-cell Lymphoma with RCHOP regimen and X drugs under the guidance of Next Generation Sequencing

Active, not recruitingChiCTR2300068820

The First Affiliated Hospital of Zhejiang University Medical CollegeDiffuse large B-cell Lymphoma

Start: 2023-03-01Updated: 2023-05-22

Phase 2

A multicenter, double-arm, randomized, prospective II phase controlled clinical trial to evaluate the efficacy and safety of dexitabine combined with R-GDP compared with R-CHOP in patients with mid-term PET-CT positive newly diagnosed diffuse large B-cell lymphoma ((DLBCL)).

RecruitingChiCTR2000035106

Union Medical College Affiliated Hospital of Tongji Medical College, Huazhong University of Science and TechnologyDiffuse large B-cell lymphoma

Start: 2020-08-01Updated: 2020-08-03